Your browser doesn't support javascript.
loading
Resistance to bortezomib in breast cancer cells that downregulate Bim through FOXA1 O-GlcNAcylation.
Liu, Yubo; Wang, Xue; Zhu, Tong; Zhang, Nana; Wang, Lingyan; Huang, Tianmiao; Cao, Yu; Li, Wenli; Zhang, Jianing.
Afiliação
  • Liu Y; Department of Biochemistry, School of Life Science & Medicine, Dalian University of Technology, Panjin, China.
  • Wang X; Department of Biochemistry, School of Life Science & Medicine, Dalian University of Technology, Panjin, China.
  • Zhu T; Department of Biochemistry, School of Life Science & Medicine, Dalian University of Technology, Panjin, China.
  • Zhang N; Department of Biochemistry, School of Life Science & Medicine, Dalian University of Technology, Panjin, China.
  • Wang L; Department of Biochemistry, School of Life Science & Medicine, Dalian University of Technology, Panjin, China.
  • Huang T; Department of Biochemistry, School of Life Science & Medicine, Dalian University of Technology, Panjin, China.
  • Cao Y; Department of Biochemistry, School of Life Science & Medicine, Dalian University of Technology, Panjin, China.
  • Li W; Department of Biochemistry, School of Life Science & Medicine, Dalian University of Technology, Panjin, China.
  • Zhang J; Department of Biochemistry, School of Life Science & Biotechnology, Dalian University of Technology, Dalian, China.
J Cell Physiol ; 234(10): 17527-17537, 2019 08.
Article em En | MEDLINE | ID: mdl-30793308
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Neoplasias da Mama / Proteínas de Ligação a DNA / Fator 3-alfa Nuclear de Hepatócito / Bortezomib / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Neoplasias da Mama / Proteínas de Ligação a DNA / Fator 3-alfa Nuclear de Hepatócito / Bortezomib / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article